Cardinal Strategic Wealth Guidance’s AbbVie ABBV Stock Holding History

Cardinal Strategic Wealth Guidance’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$711K	Sell	3,269 -78	-2%	-$17.3K	0.19%	30
2025 Q4	$765K	Sell	3,347 -368	-10%	-$83.8K	0.2%	30
2025 Q3	$860K	Hold	3,715	–	–	0.23%	29
2025 Q2	$690K	Sell	3,715 -116	-3%	-$21.6K	0.2%	29
2025 Q1	$803K	Sell	3,831 -53	-1%	-$10.3K	0.26%	27
2024 Q4	$690K	Hold	3,884	–	–	0.22%	30
2024 Q3	$767K	Hold	3,884	–	–	0.25%	29
2024 Q2	$666K	Sell	3,884 -59	-1%	-$9.77K	0.24%	29
2024 Q1	$718K	Hold	3,943	–	–	0.27%	29
2023 Q4	$611K	Hold	3,943	–	–	0.24%	36
2023 Q3	$588K	Sell	3,943 -45	-1%	-$6.61K	0.27%	36
2023 Q2	$535K	Sell	3,988 -132	-3%	-$19.4K	0.24%	37
2023 Q1	$655K	Sell	4,120 -46	-1%	-$7.03K	0.3%	32
2022 Q4	$674K	Hold	4,166	–	–	0.32%	40
2022 Q3	$570K	Hold	4,166	–	–	0.3%	36
2022 Q2	$639K	Sell	4,166 -77	-2%	-$11.8K	0.33%	37
2022 Q1	$690K	Hold	4,243	–	–	0.32%	42
2021 Q4	$575K	Hold	4,243	–	–	0.27%	47
2021 Q3	$458K	Hold	4,243	–	–	0.24%	48
2021 Q2	$478K	Sell	4,243 -3	-0.1%	-$338	0.25%	47
2021 Q1	$458K	Sell	4,246 -15	-0.4%	-$1.6K	0.27%	46
2020 Q4	$454K	Hold	4,261	–	–	0.27%	39
2020 Q3	$372K	Hold	4,261	–	–	0.26%	39
2020 Q2	$416K	Buy	4,261 +3	+0.1%	+$264	0.31%	37
2020 Q1	$323K	Hold	4,258	–	–	0.3%	38
2019 Q4	$377K	Buy	+4,258	New	+$353K	0.32%	44

Other funds holding ABBV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Cardinal Strategic Wealth Guidance's ABBV Position: Q1 2026 in Review

Cardinal Strategic Wealth Guidance reduced its AbbVie (ABBV) stake by 2.3% in Q1 2026, selling an estimated $17.3K and leaving 3,269 shares worth $711K. The position accounts for 0.19% of the portfolio, ranked #30.

Cardinal Strategic Wealth Guidance first reported a position in ABBV in Q4 2019 and has held it in 26 quarters since. The position peaked at $860K in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

Cardinal Strategic Wealth Guidance held 3,269 shares of AbbVie worth $711K as of Q1 2026.
Cardinal Strategic Wealth Guidance sold 78 AbbVie shares in Q1 2026, an estimated $17.3K.
AbbVie made up 0.19% of Cardinal Strategic Wealth Guidance's portfolio in Q1 2026, its #30 holding.
Cardinal Strategic Wealth Guidance first reported a position in AbbVie in Q4 2019 and has held it in 26 quarters since.
Cardinal Strategic Wealth Guidance's AbbVie position peaked at $860K in Q3 2025.
4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Cardinal Strategic Wealth Guidance's 13F filing for Q1 2026, filed 20 Apr 2026.